Search

everythinglearnresearchcommunity

for

Search:↓

New insights in skin conditions show a complex link between certain moles and melanoma, improved hair loss treatments, and the need to identify different types of lupus.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.